Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended from time to time, please find the enclosed investor presentation for the Unaudited (St...
Date: November 01, 2023
To BSE Limited 1st Floor, P.J. Towers, Dalal Street, Mumbai - 400001 Scrip Code: 506642
To National Stock Exchange of India Limited Exchange plaza, C-1, Block G, Bandra Kurla Complex, Bandra (E), Mumbai - 400051, India Symbol: SADHNANIQ
Subject: Investor Presentation for the Quarter ended September 30, 2023
Reference: Unaudited Financial Results (Standalone and Consolidated) of the
Company, for the quarter ended September 30, 2023
Dear Sir/Madam,
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended from time to time, please find the enclosed investor presentation for the Unaudited (Standalone and Consolidated) Financial Results for the quarter ended September 30, 2023.
Kindly take the same on your records.
FOR SADHANA NITRO CHEM LIMITED
____________________________ Nitin Rameshchandra Jani Company Secretary Membership No.: A4757
Encl. As above
Sadhana Nitro Chem Limited
Investor Presentation Q2FY24
Sadhana Nitro Chem Ltd. - Investor Presentation Q2FY24
Contents
From the Desk of the Managing Director About Us Overview PAP Expansion Highlights Trade Our Journey Health, Safety & Environment Our Mission & Values Key Attributes of the Company Management Team Research & Development Socially Responsible Waste & Effluent Management Solid Waste Disposal
Liquid Effluent Waste Disposal Product Portfolios Capacities Product Processes: Nitrobenzene Chain MAP ODB2 PAP Corporate Social Responsibility Income Statement Balance Sheet Financials Summary Capital Markets Data
Sadhana Nitro Chem Ltd. - Investor Presentation Q2FY24
From the Desk of the Managing Director
We are thrilled to announce outstanding financial performance for Q2FY24 & H1FY24. Our Revenue from Operations experienced considerable growth, increasing by 15% from Rs. 36.53 Cr in Q2FY23 to Rs. 42.01 Cr in Q2FY24. This growth can be primarily attributed to the steady increase in global demand for our products, with a particular focus on ODB2, showcasing the strength and appeal of our offerings in international markets.
In addition to our revenue growth, our EBITDA witnessed an impressive surge, rising by a remarkable 173.36% from Rs. 4.58 Cr in Q2FY23 to Rs. 12.52 Cr in Q2FY24. This increase can be attributed to softening of certain raw material prices. These cost reductions have positively impacted our EBITDA, reinforcing our operational efficiency. Our efforts in improving our operational efficiency are further highlighted by the significant improvement in EBITDA margins, which expanded from 12.42% in Q2FY23 to 29.81% in Q2FY24, an impressive gain of 1739 basis points.
For Q2FY24, export sales contributed to 25.92% of our total revenues. Dumping of goods due to high Chinese inventories have kept the sales growth minimal in H1, as we see Chinese inventories reduce, we expect that with the steady increase in global demand and with our new capacities coming online, H2FY24 will have larger revenues than H1FY24. This is particularly true for exports, but we see local markets demand growing as well.
As a background, we see that the war in Europe caused higher speculative prices for the last year and a half for commodities, additionally, lower exports from the Chinese caused them to dump inventories for the last six months. In the last two months we have seen raw material/commodity prices reduce and move towards steady prices. Chinese stocks are also expected to reduce to minimal levels in the coming months, with them having to manufacture fresh product leading to end prices going up. These factors align well with our increased capacities coming online such that we can enjoy the benefits of steadily increasing prices over H2 as sales increase.
We express our gratitude to our dedicated employees, loyal customers, and supportive stakeholders for their unwavering trust and contribution to our success. Looking ahead, we remain committed to delivering on our promises, driving innovation, and creating long-term value for our shareholders and the community we serve.
Sadhana Nitro Chem Ltd. - Investor Presentation Q2FY24
About Our Company
Established in 1973, Sadhana Nitro Chem Ltd. (SNCL), is a leading manufacturer specializing in intermediate specialty chemicals. Operating from its state-of-the-art facility Roha, which is spread over 22 acres SNCL is a government recognised 2-Star Golden Export House, with 80% of the company's sales being dedicated to exports. SNCL has been awarded from the PLI scheme for manufacturing 36000 TPA of PAP in 2021, with the current production run rate of 3000 TPA.
PAP is the used in paracetamol amongst other leading prescription drugs in the world. SNCL is a symbol of commitment to quality and social responsibility. The company holds ISO certifications for ISO 9001:2008, ISO 14001:2004, OHSAS 18001:2007, and SA (8000). SNCL is listed on both BSE: 506642 and NSE: SADHNANIQ, and is currently celebrating its 50" year as a publicly listed company.
Sadhana Nitro Chem Ltd. - Investor Presentation Q2FY24
Overview
248 team members
22 acres of manufacturing facility
Over 20+ international clients
711 tonnes exported in FY2023
12 chemicals in the product line
50th year of being publicly listed
Sadhana Nitro Chem Ltd. - Investor Presentation Q2FY24
PAP Expansion Highlights
Manufacturing
2nd Facility in the world to manufacture PAP from Nitrobenzene; 1st outside North America
Production Approval
Approval from MPCB received for consent to establish production
Global Quality Check Sadhana’s PAP surpasses standards set by global competitors
International Approval
Approved by global clients including those based in Europe, Japan & Turkey
Environment Friendly PAP produced from Nitrobenzene fits the worlds ESG focus since it is less polluting
Investment ₹100 Crores invested in this project
Sadhana Nitro Chem Ltd. - Investor Presentation Q2FY24
Trade
Canada
USA
Switzerland
UK
Germany
South Korea
Spain
UAE
International Trade
Export Sales
80% of sales come from exports to Belgium, Netherlands, Thailand, USA, UK, Switzerland, UAE, South Korea, Spain, Hong Kong, China, Japan, Canada, Taiwan, Czech Republic, Italy
Domestic Trade
Indian Sales
Domestic sales are mainly in Punjab, Delhi, Maharashtra, Gujarat, Telengana, Tamil Nadu.
Japan
China
Sadhana Nitro Chem Ltd. - Investor Presentation Q2FY24
Our Journey
1
2
3
4
5
1973 Founded the company and listed on the Bombay Stock Exchange
1975 Commenced production of Nitrobenzene
1979 Forward Integration of Nitrobenzene into Dye Intermediates
1987 Expansion of capacities of dyes intermediates
1995 Commenced production of Meta-Amino Phenol (MAP)
6
1996
Started our European subsidiary, commenced manufacture of 2,5 ANDS & 2,4 ANDS
12
11
10
2013 ISO 14001:2004, OHSAS 18001:2007. Debottlenecked MAP capacity to 2500 tons. Completed 40 years
2009 Certified ISO-9001:2008, (SA) 8000 by L’ Oreal
2006 Increased MAP capacity to 2000 TPA by adding a third plant
9
2005
8
2002
Started Production of Colour Former (ODB1 and ODB2, 500TPA)
Added MetaAmino- Phenol (MAP) Plant No. 2
7
2000 Launched BTCA Plant for the Japanese market
13
14
15
16
2017 Increased colourformer (ODB2) capacity
2019 Certified in ISO- 9001:2015, ISO- 14000:2015, ISO-45001- 2018
2019 Started manufacture of Pergafast Developer
2021 Award Government PLI scheme for import substitution of Para Amino Phenol
17
2022
Commenced commercial production 3000 TPA of Para Amino Phenol
18
19
2023 Increased ODB2 capacity to 2200 TPA
2023 (Oct) Switched to continuous production of para aminophenol (PAP) - used in paracetamol amongst other prescription drugs
Sadhana Nitro Chem Ltd. - Investor Presentation Q2FY24
Health, Safety & Environment
Our Philosophy
We are committed to complying with the environment, health & safety legislations with a focus on pollution control. Enhancing the skills and the competence of our employees through appropriate training thereby enhancing safety
Audit & Certifications
ISO 9001:2008 ISO 14001:2004 OHSAS 18001:2007 SA (8000)
Sadhana Nitro Chem Ltd. - Investor Presentation Q2FY24
Our Mission & Values
To offer & maintain the highest quality standards of our products, in offer to create long term & sustainable business relationships with our clients.
Continuously improving our products by updating technologies through customer feedback.
To become a benchmark for ethical & moral business dealings with our customers, vendors & all other business partners.
Sadhana Nitro Chem Ltd. - Investor Presentation Q2FY24
Key Attributes of the Company
Multinational Clients In the last 50 years we have had multiple control quality which multinational comprise of mainly conglomerates.
clients
Licenses & Permissions We have the requisite Maharashtra pollution control board licenses and permissions.
Product Applications
Our products are used in Agro Chemicals, Aramide Fibre, Pharma, Developers, Hair Colours, Dyes, Specialised Resins, Performance Chemicals, Rubber chemicals, Aerospace, Electronic Chemicals, Military Applications, Thermal Paper Intermediates
Management Team
Managing Director
Executive Director
Executive Chariman
Shri Asit D. Javeri he joined the Company in Year 1984 as a Director of the Company. He is now the associated with company for over 35 years
Shri Abhishek A Javeri moved back to India to take over his family business. He is a successful serial entrepreneur and and has built businesses transitioned functions required on a day to day basis. He joined the company as a director in 2007. He has turned around a market cap of Sadhana Nitro Chem Limited from INR 7 crores to INR 2500 crores.
to various
Whole Time Company Secretary
Mrs. Seema Javeri has an experinece of 12 years in administration. She joined the company as the director in 2014.
Chief Financial Officer
Shri Nitin Jani joined the industry after completing his higher studies. Prior to joing the company he had worked with the Chemical Company for 2 Years. He joined the company in the year 1984 and also joined the Board as Director in 1996.
Shri Rakesh Kothari has a rich experience of 21+ Years with CITI Banks where he has worked across operations, service, business development, relationship management including leadership roles across geographies
customer
handling
teams
Marquee Clients
Research & Development
Over the years, SNCL has been working towards new, patent pending processes, for several new products. These new processes are both built for transitioning toward green chemistry as well as streamlined for lower production costs.
SNCL has a government recognised R&D Lab with a focus on
In house Product and Process Development & Continuous improvement of our processes through R&D
Socially Responsible Waste & Effluent Management
A key attribute of our environmental conscious approach, accredited to our R&D department is improvement of existing processes and building new processes that are either effluent free or where the effluent is converted into sellable by products.
Solid Waste Disposal
Gypsum
Iron Sludge
Used by cement & fertiliser industries.
Used by steel & cement raw industries material.
as
a
solid waste effluent
Our to manufacturers, which have been approved by the pollution control board to use as their manufacturing raw materials.
sent
is
Sodium/ Potassium Sulphite
Used by paper & leather industries
Solid Waste
liquid effluent generated The the manufacturing through processes is treated & water is extracted out of the effluent. The residual solid waste is sent to Bombay Waste Management (nominated by the MPCB)
Sadhana Nitro Chem Ltd. - Investor Presentation Q2FY24
Liquid Effluent Waste Disposal
The balance liquid effluent is sent to the centralised effluent treatment plant (CETP) in Roha.
Sadhana Nitro Chem Ltd. - Investor Presentation Q2FY24
Product Portfolio
Nitrobenzene
Used as a starting point for Aniline dyes, for aniline and for other intermediates
Metanilic Acid
Used for dye intermediates
Meta Amino Phenol Intermediate for 12 applications including Aerospace, Cosmetics, Agro, Pharma, Military, etc.
Aniline 2,5 Disulphonic Acid Intermediate for Optical brightening agents and dyes
1,2,3,4- Butanetetracarboxylic acid Intermediate for Halogen Light Stabilisers
3,3 Dinitro Diphenyl Sulphone
Intermediate for Aerospace and lightweight resins
Sadhana Nitro Chem Ltd. - Investor Presentation Q2FY24
Product Portfolio
3,3 Di Amino Diphenyl Sulfone
Intermediate for Aerospace and lightweight Resins
Para Amino Phenol
Key Active Ingredient for Paracetamol
ODB2
Colourformer used for thermal paper for labels, Point of Sales, Airline tickets, baggage tags.
Aniline Oil
DEAP
PFD201
Intermediate for dyes and pharma applications
Intermediate for Dyes
Developer for Thermal paper
Sadhana Nitro Chem Ltd. - Investor Presentation Q2FY24
Capacities
PRODUCT
TPA
PRODUCT
TPA
MAP
2500
BTCA
500
PARA AMINO PHENOL (PAP)
3000
ANILINE 2,5
1400
ANILINE
600
AMMONIUM SULPHATE
OAP
4,4 ODA
4500
60
150
ODB2
2200
PFD201
3,3 DNDS
250
300
NB
12000
DEMAP
500
Sadhana Nitro Chem Ltd. - Investor Presentation Q2FY24
New Products Note: PLI Awarded for PAP for 36000 TPA
Product Process: Nitrobenzene Chain
Sadhana Nitro Chem Ltd. - Investor Presentation Q2FY24
MAP
Meta Aminophenol/3- Amino Phenol
It is used in 12 different specialised applications including cosmetics, modified para aerospace, colourformers, developers, Epoxy Resins, Electronic Chemicals, Pharma, Agro chemicals, dyes etc.
aramid
fibres,
Note: Along with being largest manufacturer of MAP globally, SNC is the only manufacture that has it’s MAP qualified for every one of the 12 end applications of the product
Highlights
SNCL is the largest supplier to Loreal worldwide
SNCL only supplier to several MNCs
Growing usage in Agro chemicals
Sadhana Nitro Chem Ltd. - Investor Presentation Q2FY24
Why our MAP?
Chinese Manufacturers
SNCL
Solvent is used in the process. Therefore impurities enter the end product. Purity - 98%
No solvent is used in the process. Crude MAP is directly distilled into flakes. Purity - 99.95%
Off white granules
White Flakes
Dependent on sourcing intermediates.
Backward Integrated from Benzene to MAP
Not approved for high end applications such as epoxy resins and para aramid fibres.
SNCL’s unique manufacturing route with a low manufacturing cost.
3000TPA
2400TPA
Sadhana Nitro Chem Ltd. - Investor Presentation Q2FY24
Capacity (TPA)
ODB2
2-phenyl amino-3-methyl-6-dibutyl amino fluoran
It is used in as a chemical in thermal paper application, widely used for credit card receipts, boarding passes, luggage tags, e-commerce slips etc.
Note: ODB 2 is backward integrated - NB to MAP and further MAP to Keto Acid, making it cost effective, quality controlled and reliable for regular supply to MNCs.
SNCL is the only ODB2 manufacturer in India. Hence, all MNCs looking for a second source of supply (Other than China) are keen to collaborate.
Highlights
SNCL’s current plant capacity: 550 TPA SNCL’s recent expansion: 2200 TPA
Current
Expansion
2,500
2,000
1,500
1,000
500
0
Sadhana Nitro Chem Ltd. - Investor Presentation Q2FY24
ODB2
Future prospects with ODB2
From 2024, SNCL will start in-house manufacturing of one of the key raw materials required for ODB2. This RM is currently being increases cost and uncertainty.
imported from China, which
With full plant integration we will be the only ODB2 manufacturer across the Globe to have a fully Consolidated ODB2 plant, which is backward integrated from NB to ODB2, with all intermediates manufactured in-house.
With the increase in capacity to 2200 TPA, we are now the biggest and most efficient, low cost manufacturer in the World. All MNCs are now eager to work with us and enter into long term contracts to ensure consistent supplies.
Chinese Manufacturing: External sourcing of AP/KA/Other RM SNCL’s Manufacturing: Fully integrated plant from NB to ODB2
Sadhana Nitro Chem Ltd. - Investor Presentation Q2FY24
ODB2
PAP
Para Amino Phenol
leading pain killer Paracetamol. It
Para Amino Phenol is the intermediate one step prior to the in world’s Aerospace, Cosmetics and others apart from it’s primary usage. India needs 60000TPA of PAP to be imported from China for Paracetamol, however due to permanent shutdowns and effluent issues only 15000TPA per year is able to be imported.
is also used
SNCL has been manufacturing Nitrobenzene since 1975. Through R&D, lab trials and pilot trials SNCL has built a patent pending process for manufacturing PAP from Nitrobenzene. This has been certified by both the ICT (formerly UDCT) & by the Department of Pharmaceuticals, moreover, the ICT has certified the process as being 100% effluent free and zero discharge.
The uniqueness of our process is that through a single stage Hydrogen Reduction of Nitrobenzene, PAP is created along with four other saleable co-products, Aniline, Ammonium Sulphate, Ortho Amino Phenol & 4,4, Oxy Dianiline. It is not only a cleaner process but also more sustainable than the current process manufactured through PNCB.
Sadhana Nitro Chem Ltd. - Investor Presentation Q2FY24
PAP
Production Linked Incentive Scheme
Sadhana Nitro Chem has been awarded from the PLI scheme for manufacturing of 36000 TPA of PAP. The company is rapidly scaling at a current run rate of about 3000 TPA.
Economics
it
is based on
SNCL’s cost of manufacturing is sustainable in the long term in as indigenously manufactured Nitrobenzene compared to PAP manufacturers that rely on PNCB procurement.
locally sourced raw materials
Chinese Manufacturing Route: Through reduction of PNCB SNCL’s Manufacturing Route: Catalytic Hydrogen Reduction of Nitro Benzene
Sadhana Nitro Chem Ltd. - Investor Presentation Q2FY24
Manufacturers
Process
Chinese Manufacturers
PNCB Route
Sadhana Nitro Chem
NB Route
Indian Manufacturers
PNCB Route
Para Aminophenol
PNCB Route
NB Route
Highly Polluting
Ammonium Sulphate is a by-product which is a raw material for Fertilisers
Greyish product requiring 10% purification additional cost overhead
Pure white product
Permissions to manufacture are reducing due to polluting process
There is no effluent in this clean process and so permissions are easier
No reusable By-product
Aniline, OAP and ODA are co products which is used in the Dye, Tyre, Pharma, Electronic and Aerospace industries
High and unstable cost of production due to fluctuation PNCB prices
Lower cost of production giving long term competitiveness
Usage
Sadhana Nitro Chem is on the way to become the largest PAP manufacturer in the world and in subsequently one of the top 3 Paracetamol manufacturers in the world.
Supply
Supply in China before shutdowns 150,000 TPA Supply in China post shutdowns 80,000-100,000 TPA
Sadhana Nitro Chem Ltd. - Investor Presentation Q2FY24
PAP Global Demand - 160000 TPA & growing
Manufacturers
PAP Supply Spread
India 10%
USA 12%
1,50,000
1,00,000
50,000
0
Chinese
Other
Indian
China 78%
Sadhana Nitro Chem Ltd. - Investor Presentation Q2FY24
Corporate Social Responsibility
The promoter’s family has set up several charitable institutions dating back over a hundred years. The objectives of the trusts vary from medical & healthcare to education & women reform. The institutions are primarily for the low income and underprivileged. Our impact has helped over ten thousand people.
Women’s Reform Ashram Mumbai Central, Mumbai
Student’s Hostel Mumbai Central, Mumbai
Healthcare Dharamshala, CP Tank, Mumbai
Sadhana Nitro Chem Ltd. - Investor Presentation Q2FY24
Income Statement Highlights
Particulars (Rs. Crores except EPS)
Q2FY24
Q2FY23
Revenue from Operations
Other Income
Total Revenue
Total Expenses excluding Depreciation, Amortization & Finance Cost
EBITDA
EBITDA Margin (%)
Depreciation & Amortization
Finance Cost
PBT before Exceptional Item
Exceptional Items
PBT
Tax
PAT
PAT Margin %
Other comprehensive profit / loss
Net PAT
Diluted EPS
42.01
-0.01
42
29.48
12.52
29.81%
3.82
4.49
4.21
0
4.21
1.64
2.57
6.12%
0.13
2.70
0.10
36.53
0.36
36.89
32.31
4.58
12.42%
1.67
2.29
0.62
0
0.62
0.99
-0.37
-1.00%
0.41
0.04
-0.01
YoY%
15.00%
13.85%
173.36%
1739 bps
579.03%
6650.00%
Q1FY24
H1FY24
H1FY23
39.41
0.73
40.14
31.56
8.58
81.42
0.72
82.14
61.04
21.1
63.97
1.63
65.60
57.18
8.42
YoY%
27.28%
25.21%
150.59%
21.38%
25.69%
12.84%
1285 bps
3.79
4.32
0.47
0
0.47
0.41
0.06
0.15%
0.02
0.08
0.002
7.61
8.81
4.68
0
4.68
2.05
2.63
3.25
3.56
1.61
0
1.61
0.96
0.65
3.20%
0.99%
0.15
2.78
0.11
0.14
0.79
0.03
190.68%
304.62%
221 bps
251.90%
Sadhana Nitro Chem Ltd. - Investor Presentation Q2FY24
Balance Sheet
PARTICULARS
HALF YEAR ENDED
YEAR ENDED
PARTICULARS
HALF YEAR ENDED
YEAR ENDED
Consolidated (Rs. in Crores)
EQUITY AND LIABILITIES EQUITY
(a) Equity Share Capital
(b) Other Equity
Sub Total (1)
LIABILITIES
Non-current liabilities
(a) Financial Liabilities
(i) Borrowings
(ia) Lease Liabilities
(ii) Other financial Liabilities
(b) Provisions
(c) Deferred Tax Liabilities (Net)
Sub Total (2)
Current Liabilities
(a) Financial Liabilities
(i) Borrowings
(ia) Lease Liabilities
(ii) Trade payables
(a) Due to micro & small enterprises
(b) Due to other than micro & small enterprises
(iii) Other financial liabilities
(b) Provisions
(c ) Income Tax Liabilities (Net)
(d) Other Current Liabilities
Sub Total (3)
Total (1) + (2) + (3)
UNAUDITED
30.09.2023
24.71
204.12
228.83
51.45
0.42
4.53
5.25
61.65
120.35
4.09
3.61
26.23
18.31
1.04
38.70
4.60
216.93
507.41
AUDITED
31.03.2023
A. Assests
20.21
205.87
226.08
59.77
2.48
4.75
5.28
72.78
72.08
4.42
2.07
31.41
11.82
0.74
40.25
5.20
167.99
466.35
1. Non Current Assets
(a) Goodwill on Consolidation
(b) Property, Plant and Equipment
(c ) Capital work- in - progress
(d) Intangible Assets Under Development
(e) Financial Assets
(i) Investments
(ii) Loans
(iii) Other financial assets
(f) Deferred Tax Assets (net)
(g) Other non current assets
Sub Total (1)
2. Current assets
(a) Inventories
(b) Financial Assets
(i) Current investment
(ii) Trade Receivables
(iii) Cash and Cash Equivalents
(iv) Bank Balances other than (iiiI) above
(v ) Loans & Advances
(vi ) Other Financial Assets
(c) Income Tax Assets
(d) Other Current Assets
Sub Total (2)
Total (1) + (2)
Sadhana Nitro Chem Ltd. - Investor Presentation Q2FY24
Consolidated (Rs. in Crores)
UNAUDITED
30.09.2023
AUDITED
31.03.2023
142.25
41.97
4.01
3.72
26.22
218.17
115.01
5.67
103.54
0.19
7.59
3.49
3.07
41.31
9.37
289.24
507.41
143.73
24.50
4.01
2.83
27.32
202.39
115.86
5.77
65.56
1.33
7.63
3.31
4.84
44.94
14.72
263.96
466.35
Financials Summary - Q2FY24
Revenue From Operations
Revenue from Operations
Growth
In INR Crores
39.41
36.53
42.01
15%
50
40
30
20
10
0
3
2
1
0
-1
PAT & PAT Margin
PAT
PAT Margin
In INR Crores
2.57
6.12%
15
10
EBITDA & EBITDA Margin
EBITDA
EBITDA Margin
In INR Crores
12.52
29.81%
8.58
-0.37
-1%
0.06
0.15%
5
4.58
21.38%
12.42%
0
Q2FY23
Q1FY24
Q2FY24
Q2FY23
Q1FY24
Q2FY24
Q2FY23
Q1FY24
Q2FY24
Sadhana Nitro Chem Ltd. - Investor Presentation Q2FY24
Financials Summary - H1FY24
Revenue From Operations
Revenue from Operations
Growth
100
In INR Crores
81.42
27.28%
63.97
75
50
25
0
EBITDA & EBITDA Margin
PAT & PAT Margin
EBITDA
EBITDA Margin
PAT
PAT Margin
In INR Crores
21.1
25.69%
25
20
15
10
5
0
8.42
12.84%
In INR Crores
3
2
1
0
0.65
0.99%
H1FY23
2.63
3.20%
H1FY24
H1FY23
H1FY24
H1FY23
H1FY24
Sadhana Nitro Chem Ltd. - Investor Presentation Q2FY24
Capital Markets Data
5th May 2023 Listed on NSE
Turned Ex Bonus
Price Data (as on close 27th Oct 2023)
Face Value (INR)
Market Price (INR)
1.00
96.71
52 Week (High/Low) (INR)*
124.17/66.00
Market Cap (in Cr)
2389.30
1 Year Daily Avg Trading Volume
257517
Shareholding Pattern
Public 28.9%
Promoter 71.1%
Data as per BSE & NSE (Volume average combined for BSE & NSE, price data as per BSE) Price adjusted for bonus
Sadhana Nitro Chem Ltd. - Investor Presentation Q2FY24
Disclaimer
Certain statements in this release concerning our future growth prospects are forward-looking statements, which involve a number of risks and uncertainties that could cause actual results to differ materially from those in such forward-looking statements. The risks and uncertainties relating to these statements include, but are not limited to, risks and uncertainties regarding the success of our investments, risks and uncertainties regarding fluctuations in earnings, our ability to manage growth, our ability to successfully implement our strategy, our research and development efforts, changes in the value of the Rupee and other currency changes, intense competition in the industry including those factors which may affect our cost advantage, wage increases in India, our ability to attract and retain highly skilled professionals, time and cost overruns on fixed-price, fixed-time frame contracts, client industry segment concentration, our ability to manage our concentration, restrictions on international operations, in telecommunication networks or system failures, our ability to successfully complete and integrate potential acquisitions, liability for damages on our service contracts, withdrawal of governmental fiscal incentives, political instability and regional conflicts, legal restrictions on raising capital or acquiring companies outside India, and unauthorized use of our intellectual property and general economic conditions affecting our industry. Sadhana Nitro Chem Limited may, from time to time, make additional written and oral forward-looking statements, including statements contained in the company’s filings with the Securities and Exchange Board of India, Stock Exchange and our reports to shareholders. The company does not undertake to update any forward-looking statements that may be made from time to time by or on behalf of the company.
focus areas, disruptions
reduced demand
in our key
immigration,
technology
for
Sadhana Nitro Chem Ltd. - Investor Presentation Q2FY24
Thank You
Investor Relations Advisor: Brijesh K. Impress Strategic Communications Private Limited Email: sadhananitro@impressir.com
Sadhana Nitro Chem Ltd. - Investor Presentation Q2FY24